Latest pharmaceutical industry Stories
ERT’s Solutions Utilized in over Half of FDA Approvals PHILADELPHIA (PRWEB) January 08, 2015 ERT, a leading global solution provider for high-quality
Increased Competition Lowers Drug Costs Washington D.C.
BETHESDA, Md., Jan. 8, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a U.S.
Increased Competition Lowers Drug Costs WASHINGTON, Jan.
CHENGDU, China, Jan. 8, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc.
Biologics, oncology drugs and blood-based products will be key revenue-generating segments, finds Frost & Sullivan LONDON, Jan.
LONDON, January 8, 2015 /PRNewswire/ -- EMA's Committee for Orphan Medicinal Products recommends Magnus Growth Therapy for Placental Insufficiency
LONDON and BOSTON, January 8, 2015 /PRNewswire/ -- Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is pleased to
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.